Shareholders Equity ratio Analysis of Halozyme Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointShareholders Equity of HALO
Dec-234.84Very Poor Shareholders Equity | Dec-229.22Very Poor Shareholders Equity | Growth-47.56% |
Shareholders Equity Analysis of Halozyme Therapeutics Inc
| Shareholder to Equity Ratio 4.84 of Halozyme Therapeutics Inc indicates that shareholders own a low proportion of the assets of the company. |
| Shareholders Equity Ratio of HALO drastically fell by -47.56 % this year. |
| Shareholders Equity Ratio with value of 26.05 was highest in Year Dec-20 in last Five Years. |
| Shareholders Equity Ratio of HALO trending down for at least three Years. |
| Latest Shareholders Equity Ratio with value of 4.84 is lower than Average Shareholders Equity of 14.83 in last five years. |
Other Shareholders Equity Related Info of HALO that may interest you.
Halozyme Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| HALO | 44.29 | 43.35 | 2.17 % | Biotechnology |
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation. more ..
Shareholders Equity Related Ratios
| DebtToEquityRatio | ReturnOnEquity |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Shareholders Equity of Halozyme Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Shareholders Equity | 4.84 | 9.22 | 17.83 | 26.05 | 16.22 | 56.53 | 40.07 |
| Change | -47.56 % | -48.29 % | -31.53 % | 60.61 % | -71.32 % | 41.07 % | 422.65 % |
FY Chart of Shareholders Equity of Halozyme Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)